These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1348 related articles for article (PubMed ID: 31124340)

  • 21. Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis.
    Ma L; Wei J; Zeng Y; Liu J; Xiao E; Kang Y; Kang Y
    Drug Deliv; 2022 Dec; 29(1):440-453. PubMed ID: 35099348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hesperitin derivative-11 suppress hepatic stellate cell activation and proliferation by targeting PTEN/AKT pathway.
    Li WX; Chen X; Yang Y; Huang HM; Li HD; Huang C; Meng XM; Li J
    Toxicology; 2017 Apr; 381():75-86. PubMed ID: 27818223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Huangqi Decoction, a compound Chinese herbal medicine, inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-β axis.
    Dong BS; Liu FQ; Yang WN; Li XD; Shi MJ; Li MR; Yan XL; Zhang H
    J Integr Med; 2023 Jan; 21(1):47-61. PubMed ID: 36456413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4.
    He Y; Huang C; Sun X; Long XR; Lv XW; Li J
    Cell Signal; 2012 Oct; 24(10):1923-30. PubMed ID: 22735812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
    Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
    Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hsa_circ_0072765 knockdown inhibits proliferation, activation and migration in transforming growth factor-beta (TGF-β)-induced hepatic stellate cells (HSCs) by the miR-197-3p/TRPV3 axis.
    Jin Y; Guo X; Zhang R; Yan C
    Histol Histopathol; 2023 Nov; 38(11):1295-1306. PubMed ID: 36714978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sestrin 2 Attenuates Rat Hepatic Stellate Cell (HSC) Activation and Liver Fibrosis via an mTOR/AMPK-Dependent Mechanism.
    Hu YB; Ye XT; Zhou QQ; Fu RQ
    Cell Physiol Biochem; 2018; 51(5):2111-2122. PubMed ID: 30522100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow mesenchymal stem cells inhibit hepatic fibrosis via the AABR07028795.2/rno-miR-667-5p axis.
    Feng Y; Li Y; Xu M; Meng H; Dai C; Yao Z; Lin N
    Stem Cell Res Ther; 2022 Jul; 13(1):375. PubMed ID: 35902883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mouse Anxa6/miR-9-5p/Anxa2 axis modulates TGF-β1-induced mouse hepatic stellate cell (mHSC) activation and CCl
    Liao J; Zhang Z; Yuan Q; Luo L; Hu X
    Toxicol Lett; 2022 Jun; 362():38-49. PubMed ID: 35483553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
    Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
    Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effects of oxymatrine on hepatic stellate cells activation through TGF-β/miR-195/Smad signaling pathway.
    Song LY; Ma YT; Fang WJ; He Y; Wu JL; Zuo SR; Deng ZZ; Wang SF; Liu SK
    BMC Complement Altern Med; 2019 Jun; 19(1):138. PubMed ID: 31221141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-489-3p Represses Hepatic Stellate Cells Activation by Negatively Regulating the JAG1/Notch3 Signaling Pathway.
    Li J; Dong S; Ye M; Peng G; Luo J; Wang C; Wang J; Zhao Q; Chang Y; Wang H
    Dig Dis Sci; 2021 Jan; 66(1):143-150. PubMed ID: 32144602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2.
    Wang Y; Du J; Niu X; Fu N; Wang R; Zhang Y; Zhao S; Sun D; Nan Y
    Cell Death Dis; 2017 May; 8(5):e2792. PubMed ID: 28518142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways.
    Huang Q; Zhang X; Bai F; Nie J; Wen S; Wei Y; Wei J; Huang R; He M; Lu Z; Lin X
    Int Immunopharmacol; 2019 Jan; 66():41-51. PubMed ID: 30419452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-200c Accelerates Hepatic Stellate Cell-Induced Liver Fibrosis via Targeting the FOG2/PI3K Pathway.
    Ma T; Cai X; Wang Z; Huang L; Wang C; Jiang S; Hua Y; Liu Q
    Biomed Res Int; 2017; 2017():2670658. PubMed ID: 28691020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-β pathway.
    Yang X; Ma L; Wei R; Ye T; Zhou J; Wen M; Men R; Aqeilan RI; Peng Y; Yang L
    Signal Transduct Target Ther; 2020 Jun; 5(1):75. PubMed ID: 32499481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
    Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
    J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sennoside A prevents liver fibrosis by binding DNMT1 and suppressing DNMT1-mediated PTEN hypermethylation in HSC activation and proliferation.
    Zhu H; He C; Zhao H; Jiang W; Xu S; Li J; Ma T; Huang C
    FASEB J; 2020 Nov; 34(11):14558-14571. PubMed ID: 32946656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
    Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
    Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 68.